Sunshine Biopharma, Inc. (SBFM)
1.15
-0.02
(-1.71%)
USD |
NASDAQ |
Sep 03, 10:01
Sunshine Biopharma Price to Book Value : 0.0998 for Sept. 3, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 0.1015 |
| September 01, 2026 | 0.0981 |
| August 31, 2026 | 0.0972 |
| August 28, 2026 | 0.0998 |
| August 27, 2026 | 0.1102 |
| August 26, 2026 | 0.1076 |
| August 25, 2026 | 0.0989 |
| August 24, 2026 | 0.1007 |
| August 21, 2026 | 0.1007 |
| August 20, 2026 | 0.1007 |
| August 19, 2026 | 0.1015 |
| August 18, 2026 | 0.0972 |
| August 17, 2026 | 0.0972 |
| August 14, 2026 | 0.0998 |
| August 13, 2026 | 0.1041 |
| August 12, 2026 | 0.105 |
| August 11, 2026 | 0.1067 |
| August 10, 2026 | 0.1059 |
| August 07, 2026 | 0.1067 |
| August 06, 2026 | 0.1215 |
| August 05, 2026 | 0.1154 |
| August 04, 2026 | 0.1137 |
| August 03, 2026 | 0.1015 |
| July 31, 2026 | 0.1015 |
| July 30, 2026 | 0.1067 |
| Date | Value |
|---|---|
| July 29, 2026 | 0.1067 |
| July 28, 2026 | 0.1241 |
| July 27, 2026 | 0.1328 |
| July 24, 2026 | 0.144 |
| July 23, 2026 | 0.1484 |
| July 22, 2026 | 0.1571 |
| July 21, 2026 | 0.1519 |
| July 20, 2026 | 0.1501 |
| July 17, 2026 | 0.1562 |
| July 16, 2026 | 0.1588 |
| July 15, 2026 | 0.1614 |
| July 14, 2026 | 0.1666 |
| July 13, 2026 | 0.1692 |
| July 10, 2026 | 0.1814 |
| July 09, 2026 | 0.1857 |
| July 08, 2026 | 0.184 |
| July 07, 2026 | 0.1805 |
| July 06, 2026 | 0.1892 |
| July 02, 2026 | 0.1831 |
| July 01, 2026 | 0.1892 |
| June 30, 2026 | 0.1822 |
| June 29, 2026 | 0.0481 |
| June 26, 2026 | 0.0497 |
| June 25, 2026 | 0.0488 |
| June 24, 2026 | 0.0465 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.801 |
| Alnylam Pharmaceuticals, Inc. | 26.24 |
| Anika Therapeutics, Inc. | 2.073 |
| Savara, Inc. | 7.664 |
| Vericel Corp. | 5.607 |
Price to Book Value Related Metrics
| PS Ratio | 0.0226 |
| Price | 1.15 |
| Earnings Yield | -889.2% |
| Market Cap | 2.747M |